Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Amgen Surges After Beating Q2 Earnings Expectations with Strong Revenue Growth

Guavy AI Editorial Team
Instruments
AMGN
Share

Biopharmaceutical company Amgen's shares rose by 4% after it reported stronger-than-expected earnings for the second quarter of 2026. The company posted a revenue of $10.05 billion, surpassing Wall Street estimates of around $9.40 billion.

The 10% year-over-year increase in revenue was driven by the growth of 22 products with double-digit sales growth and 17 products generating over $1 billion annually.

Amgen's CEO Robert Bradway highlighted robust growth from key products and confidence in future pipeline advancements supporting long-term growth.

More on Stocks

Stocks just now

Coca-Cola HBC Beats Expectations with Strong First-Half Results

Stocks 1m ago

Disney's Stock Price Surges 3.7% After Quarterly Results

Stocks 1m ago

Disney and Universal Fuel Price War with Discounts for Local Visitors

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy